Pharming Group (PHGUF) to Release Earnings on Thursday

Pharming Group (OTCMKTS:PHGUF) is anticipated to issue its quarterly earnings data on Thursday, March 13th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $76.67 million for the quarter.

Pharming Group Price Performance

OTCMKTS:PHGUF opened at $0.90 on Tuesday. The company has a market cap of $606.85 million, a price-to-earnings ratio of -45.22 and a beta of 0.91. The company has a current ratio of 3.53, a quick ratio of 2.76 and a debt-to-equity ratio of 0.53. Pharming Group has a twelve month low of $0.75 and a twelve month high of $1.20. The stock has a fifty day simple moving average of $0.91 and a 200-day simple moving average of $0.84.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.